Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acetazolamide in Central Sleep Apnea Patients on Opioid Use Disorder Medication
NCT06521476Phase 2Recruiting
- Start
- Sep 2025
- Primary completion
- Feb 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of acetazolamide in central sleep apnea (CSA). Started Sep 2025; status: recruiting.
02
Drugs
acetazolamide
03
Conditions
central sleep apnea (CSA)
Beyond the preview
Go deeper on NCT06521476.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06521476.